By effectively addressing obesity-linked OSA for many (it reversed the condition in up to 50.2% of SURMOUNT-OSA trial participants), GLP-1s prescribed by primary care physicians and other specialists are clearing the decks, allowing sleep specialists to refocus on the patients whose condition is driven by other factors
2019;6:CD011265
This article was supported by Novo Nordisk Inc., who performed a medical accuracy review
While the study opens up dialogue about the possible safety of GLP-1 medications during breastfeeding, it's crucial for women to consult with healthcare providers
Our small, slow release capsules send a signal to the brain that the stomach is already partially full
Fatigue, Depression, and The Blahs Some people on GLP-1s report a tired, flat, or unmotivated feeling